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Interstitial 14q24.3 to q31.3 deletion in a 6-year-old
boy with a non-specific dysmorphic phenotype
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Abstract
Background: Few patients with interstitial deletions in the distal long arm of chromosome 14 have been reported,
and these patients showed rather indistinct features, including growth and mental retardation and phenotypic
alterations.
Results: We describe a de novo 14q interstitial deletion in a 6-year-old boy with dysmorphic facial traits such as
hypertelorism, short and narrow palpebral fissures, broad nose with anteverted nostrils, long philtrum, thin upper lip
with cupid’s bow, prominent and everted lower lip, mildly low-set ears, as well as moderate developmental delay
and mild mental retardation. Array-CGH mapped the deletion to the region 14q24.3 to 14q31.3, including 13.11 Mb,
proximal to the imprinted genomic region of 14q32.
Conclusion: This mild phenotypic presentation suggests that the deleted segment does not contain essential
genes for early organ development. Twenty-two genes with known functions, including Neurexin III (NRXN3, OMIM
600567), map to the region deleted in the propositus.
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Background
The few reported patients with interstitial microdele-
tions in the long arm of chromosome 14 have shown a
broad and inconsistent spectrum of clinical features
caused by loss of different segments of 14q. An under-
standing of the phenotypes of these clinical disorders is
further hampered by the scarcity of reports and the fact
that most of the reported patients were diagnosed using
only traditional chromosome banding with inaccurate
and approximate mapping of the deleted segment.
Cingöz et al. [1], considering the minimal size of these
deletions in 11 patients, constructed a map for the three
shortest regions of deletion overlap. The proximal region
includes the gene encoding Neurexin III (NRXN3, MIM
600567), for which haploinsufficiency is associated with
cognitive and neurological defects.
Here, we report a male patient with a de novo deletion
of the segment 14q24.3 to q31.3, determined using
comparative genomic hybridization with microarray (array
CGH; aCGH). We also sought to correlate the clinical
findings to those of patients with deletions overlapping
that identified in the propositus. Considering that break-
point determination using only banded karyotypes is not
precise and may be inaccurate, we included only reports
with molecular determination or confirmation of the
breakpoints in our comparison.
Case presentation
The patient was a male aged 6 years and 9 months, the
only son of a 38-year-old mother and a 41-year-old father
who measured 1.58 m and 1.76 m in height, respectively,
and were healthy and nonconsanguineous. The parents re-
ported no genetic conditions or birth defects in the family.
The pregnancy was planned and uneventful. Delivery was
by cesarean section at 39 weeks and 6 days. The patient’s
birth weight was 3145 g, with a length of 49 cm and head
circumference of 33.5 cm, which are all appropriate for
the gestational age. There was no visible perinatal as-
phyxia. The postnatal course was characterized by psycho-
motor delay and muscular hypotonia.
At the first clinical evaluation at 20 months of age, he
showed mild dysmorphic features. The first tooth erupted
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at 8 months of age. Beginning at 6 months of age, he
received regular neurological and pediatric follow-ups.
The first smile was noted at the age of 2 months, roll-
ing from a ventral to a dorsal position was observed at
3 months, following objects with his eyes was observed
at 6 months, maintaining a sitting position was observed
at 8 months, maintaining a standing position was ob-
served at 10 months, responding to his name was ob-
served at 10 months, walking was observed at 20 months,
and toilet training was achieved at 2 ½ years.
At 6 months of age, physical therapy and an interdis-
ciplinary program of early stimulation were initiated. He
was discharged from physical therapy at the end of the
second year of life. Psychologic evaluation at 2 years of
age showed cognitive delay (corresponding to 1 year and
6 months). He was subjected to speech therapy due to
difficulties related to sensory-motor aspects and oral lan-
guage. According to a clinical assessment at 4 years of
age, despite having communicative intent, language
expression was quite restricted. He also had deficits in
psychomotor and cognitive executive function that im-
proved with time, especially regarding sensory integra-
tion, and he presented an attention deficit. At 5 years of
age, an evaluation of language and cognitive develop-
ment was performed using the Protocol of Observation
Behavioral [2]. The examinations revealed the following:
limited oral language, with attempts to engage in dialogue;
language disorder, especially in expressive language; deficit
in motor skills and difficulties in the understanding and
execution of tasks and games. With respect to activities of
daily living, he showed autonomy in eating and dressing.
At 6 years and 10 months of age, he measured 125 cm
in height (50th – 75th percentile), weighed 26 kg (50-75th
percentile) and had an occipital frontal circumference
(OFC) of 52 cm (25th – 50th percentile). Dysmorphologi-
cal examination revealed low-set ears with prominent
helices and lobules, hypertelorism (ICD 3.5 cm, >97th
percentile), bushy eyebrows, short nose with anteverted
nostrils, deep nasolabial furrows, small and open mouth
with an open bite and a thin vermilion, a prominent
Cupid’s bow of the upper lip and a prominent and
everted lower lip. Mild micrognathia was also observed
(Figure 1).
The propositus attends a regular school with support.
He communicates well with colleagues and teachers, and
he is able to express his wishes through language and to
understand simple conversation and demands. Further
examinations revealed the following: Magnetic reson-
ance imaging (MRI) showed an intact corpus callosum
and a small region of ischemia in the glyptic cavity of
the cerebellar region. Electroencephalography (EEG) and
audiometry results were normal, and he showed no vi-
sion problems.
Results
With regard to cytogenetic and molecular examinations,
the deletion was initially identified through G-banding.
The karyotype was interpreted as 46,XY,del(14)(q31).
However, fluorescence in situ hybridization (FISH) per-
formed in the proband showed that there was no loss of
the terminal region of chromosome 14 (band 14q32).
The precise characterization of the deletion using oligo-
nucleotide aCGH showed a loss of genomic material
corresponding to an interstitial deletion in the long arm
of chromosome 14, segment q24.3-q31.3, of approximately
13.11 Mb (UCSC Genome Browser on Human Feb. 2009
(GRCH37/hg19). Arr 14q24.3q31.3 (76,211,806-89,327,656)
×1 (Figure 2). The parental karyotypes were normal.
Discussion
Excluding pseudogenes, chromosome 14 presents a
mean gene density of 10 genes per Mb (850 genes per
85 Mb), which is close to the mean value estimated for
the whole human genome (9.3–10.8 genes per Mb) [3].
Figure 1 Patient at the ages of 2 months (A), 3 years and 5 months (B) and 6 years and 10 months (C). Note the short upturned nose,
deep philtrum, thin vermillion of the upper lip and prominent earlobes.
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Mutation analysis has revealed 21 genes on this chro-
mosome associated with genetic diseases [4]. Among
these, Holt-Oram syndrome or a syndrome similar to
Holt-Oram syndrome, has been reported in patients with
14q deletions. Furthermore, 70% of those patients fulfill-
ing strict criteria show a mutation in TBX5 on 12q24.1.
Thus, there might be a second locus for this syndrome
at 14q23.3q31.1 [5].
The propositus presented with mild to moderate devel-
opmental delay, normal growth and a pattern of indistinct
minor dysmorphic signs in the absence of organ malfor-
mations. For a comparison with previously reported pa-
tients with similar or overlapping deletions spanning at
least 10 Mb (see Table 1, in order from proximal to distal
from the proximal breakpoint), we excluded reports in
which the breakpoints were determined only through
chromosome banding because it is well known that such
methods can provide imprecise determinations leading to
incorrect interpretations (for example, a deletion classified
as terminal may turn out to be interstitial, as in our pro-
band, and vice versa). Our patient was the first to be
subjected to aCGH analysis of the deleted segment. In
contrast, using FISH with only a few and mostly flanking
markers, it is possible to overlook non-deleted or even du-
plicated stretches of DNA within a deleted segment, espe-
cially in instances of ring chromosomes [6].
Table 1 shows that except for the patient described by
LeMeur [5], the proximal breakpoints were quite similar
in all patients, ranging from bp 73.942.355 [7], patient
25 to 77,867,749 [7], patient 22, whereas the distal break-
points differed considerably, from 88,488,190 [8,9] to
98.771.224 [1,10]. However, these represent the minimal
deleted segments because the space between the last or
first present marker and the first or last deleted marker
was quite different, and some markers were not precisely
mapped. In addition, findings present in only one patient
were listed separately, and comparison was limited by the
uncertainty of whether dysmorphic findings not described
in the different case reports were absent or not considered
worth mentioning.
Our comparison of clinical features revealed that neu-
rodevelopmental features such as developmental delay,
Figure 2 Chromosome 14 aCGH profile of the patient (in red) and a reference DNA sample from a normal male (in blue). The figure
shows (A) a copy number loss corresponding to the segment 14q24.3-q31.3 in a genomic segment with the median log2 ratio shifted to -0.8
(red line). The probe log2 ratios were plotted according to genomic coordinates (based on the UCSC Genome Browser, February 2009, NCBI Build
37 reference sequence). In (B), detail of the 14q24.3-q31.3 region showing the deleted region of ~13 Mb.
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Table 1 Comparison of the clinical features of patients with interstitial 14q deletions including the segment 14q23.3 to 14q31.1
Feature 1 Le Meur 2 Zollino, case 25 3 Propositus 4 Karnitis, Byth 5 Cingöz 6 Schlade 7 Zollino 22 Total
Proximal breakpoint q23.3 q24.3 q24.3 q24.3 q24.3 q24.3 q24.3
Distal breakpoint q31.1 q32.13 q31.3 q31.3 q32.2 q32.13 q31.11
Size of the deletion in Mb 13.937.056 20.971.834 13.115.851 11.665.854 21.545.793 18.576.858 13.981.234
Minimal deletion (base pairs) 67.736.534 73.942.355 76.211.806 76.822.337 77.226.431 77.823.431 77.867.749
81.673.589 94.914.188 89.327.656 88.488.190 98.771.224 96.400.270 91.848.982
Technique used FISH/BACs FISH/BACs aCGH FISH/BACs FISH/BACs FISH/BACs FISH/BACs
Age at last examination (years) 6/12 18 6 9/12 3 6/12 10 3 19 -
Developmental delay + ++ + + + + ++ 7/7
Intellectual impairment ++ + +, mild + + ++ 7/7
Language delay + + + + + 6/6
Postnatal growth retardation + - + + 4/6
Muscular hypotonia + + + + + + 7/7
Microcephaly postnatally + - + - ¾
Ocular hypertelorism + + + + 5/5
Inner epicanthic folds + + + + 5/5
Ptosis of eyelids + + + 3/6
Downslant/palpebral fissures + + + - ¾
Flat/depressed nasal bridge + + + 3/3
Strabismus + +
Short/bulbous nose + + + + + 5/5
Deep/broad philtrum + + 2/2
Thin vermilion of the upper lip + + + + 4/4
High arched palate + + - 2/3
Abnormal dentition + + - 2/3
Micro-/retrognathia + + - + ¾
Pointed chin + + 2/3
Dysplastic/low-set ears +, asymm. + + + + 6/6
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Table 1 Comparison of the clinical features of patients with interstitial 14q deletions including the segment 14q23.3 to 14q31.1 (Continued)
Scoliosis + +
+ +
Congenital heart defect + - - - + - - 3/6
Hearing impairment +(?) + + 4/4
Findings in single patients Radial a/hypoplasia cleft
palate, mild ventricular
dilatation, maternal
balanced insertion
Myopia, aggressivity Cupid’s bow
of upper lip
Breech delivery,
central lower incisor,
transverse palmar
crease left
Blepharo-phimosis,
facial asymmetry
Brachyda-ctyly,
syndactyly 2/3 toes
Seizures, Hirsutism
Susceptible
to infections
+: present; -: absent, empty: not described Patients: 1. [5] 2. [7], case 25; 3. Present case; 4. [8,9]; 5. [1]; 6. [10]; 7. [7], case 22.
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muscular hypotonia and language delay were quite con-
sistent, as were some frequent and non-specific dys-
morphic signs including hypertelorism, inner epicanthic
folds, short and bulbous nose with a depressed bridge,
thin upper lip and dysplastic ears. However, malforma-
tions were inconsistently found, as heart defects were
only found in 3/6 patients, and different defects were
observed in one patient each. Hearing impairment was
reported 4 times, but the other studies did not report on
the presence or absence of hearing impairment, and in
the reported cases, the type was conductive and sensory-
neural, with 2 instances each.
The patient with the greatest accumulation of congeni-
tal malformations had at least 6 Mb deleted proximal of
the deletion in the other patients [5]. We did not include
the following two patients in the comparison. First,
Vaags et al. [11] reported a patient with a very small de-
letion (0.063 Mb) inside that detected in our propositus;
this patient had Asperger syndrome with NRXN3 dele-
tion. Although NRXN3 is associated with autism [12]
and lies inside our reported deletion, our propositus did
not display features of autism. Second, Shimada et al.
[12] described a 2-year-old boy with growth and severe
mental retardation, a dysmorphic pattern comparable to
that observed in our patient and MRI findings of leuko-
dystrophy. This deletion spanned 2.0 Mb, of which
0.8 Mb overlapped with the proximal deleted region in
our patient. This patient was found to have a deletion of
EIF2B2, a gene associated with leukodystrophy, which
maps outside the deletion in our propositus, who conse-
quently does not show similar neurologic symptoms.
Table 2 lists the genes with only one copy in the propos-
itus. The list shows that mutations of some of these genes,
including TTC8 (Bardet-Biedl syndrome 8), POMT2
(Walker-Warburg syndrome), GALC (Krabbe disease),
GSTS1 (Tyrosinemia Ib), and SPATA7 (Leber amaurosis
Table 2 An assembly of genes deleted in the present patient according to the Online Mendelian Inheritance in Man
(OMIM) annotation
Gene OMIM
annotation
Name/Possible function Associated syndromes
FLRT2 604807 Fibronectin-like domain-containing leucine-rich transmembrane protein 2 -
C14orf4 611720 Chromosome 14 open reading frame 4. -
SPTLC2 605713 Serine palmitoyltransferase, long-chain base subunit 2.
Sphingolipid biosynthesis.
Neuropathy, hereditary sensory, type IC.
ESRRB 602167 Estrogen-related receptor beta. Deafness, autosomal recessive 35.
NRXN3 600567 Neurexin III. Polymorphic cell surface protein expressed in neurons. -
GPR65 604620 G protein-coupled receptor 65. -
TGFB3 190230 Transforming growth factor beta-3. Arrhythmogenic right ventricular
dysplasia 1; Rienhoff Syndrome
TTLL5 612268 Tubulin tyrosine ligase-like family, member 5. Role in
glucocorticoid-mediated induction and repression.
Cone-rod dystrophy 19
TTC8 608132 Tetratricopeptide repeat domain 8. Bardet-Biedl syndrome 8.
FOXN3 602628 Forkhead box N3. -
ISM2 612684 Isthmin 2, zebrafish homolog. Secreted proteins with diverse
functions such as cell adhesion, cell angiogenesis, and
patterning of developing nervous system.
-
KCNK10 605873 Potassium channel, subfamily K, member 10. -
POMT2 607439 Protein o-mannosyltransferase 2. Walker-Warburg syndrome.
DIO2 601413 Deiodinase, iodothyronine, type II. A selenoprotein that catalyzes
the 5-prime deiodination of thyroxine (T4) to generate an active
thyroid hormone,3,3-prime,5 triiodothyronine (T3).
-
GALC 606890 Lysosomal enzyme involved in the catabolism of galactosylceramide. Krabbe disease.
GSTZ1 603758 Tyrosinemia, type Ib. Tyrosinemia, type Ib.
ALKBH1 605345 AlkB, E. coli homolog. Protects cells from mutation and cell death
caused by SN2-type alkylating agents.
-
NGB 605304 Neuroglobin. Lower resistance to ischemia and neurofibrillary tangles. Alzheimer disease.
TSHR 603372 Thyroid stimulating hormone receptor Hyperthyroidism,familial gestational.
SPATA7 609868 Spermatogenesis associated 7 Leber congenital amaurosis 3
Retinitis pigmentosa
SEL1L 602329 Suppressor of lin-12-like (C. elegans) -
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3), produce well-known clinical entities. However, findings
characteristic for these conditions are not present in our
propositus because hemizygosity would not cause the con-
dition unless the remaining allele carries a mutation or in
the case of uniparental disomy. Except for NRXN3 and
EIF2B2 (see above), the genes listed in Table 2 are not
known to cause specific phenotypes if one allele is ab-
sent. This is different from more proximal deletions that
cause anophthalmia, cataract (SIX1, BMP4)), hearing
loss (OTX2), abnormal pituitary function (SIX4 and SIX6)
and polydactyly, all due to hemizygosity of the related
genes [13-16]. In patients with deletions distal from that
in the propositus and mostly terminal, including ring
chromosomes, the clinical patterns tend to be indistinct,
mostly showing patterns of dysmorphic signs [17,18]. One
exception is the case of a mother and daughter who both
showed hemifacial microsomia [19]; however, the latter
could theoretically be independent of the small deletion.
Genomic imprinting could theoretically cause part of
the clinical picture of our propositus. Sutton and Schaffer
[20] suggested that 14q23-q32 is likely an area where
imprinted genes may reside because distinct phenotypes
have been associated with both maternal and paternal uni-
parental disomy (UPD) for this chromosome. However,
according to the authors, these features mapped to other
segments, and they were not present in the propositus.
Unfortunately, we could not determine the parental origin
of the deletion in our propositus. Generally, most intersti-
tial deletions are paternal in origin. However, because ma-
ternal UPD is correlated with profound intrauterine and
postnatal growth deficiency and early puberty, loss of a
critical imprinted segment in the region 14q24-q31 is un-
likely because the propositus does not show this key fea-
ture. In addition, the clinical picture of paternal UPD 14 is
more severe and less consistent; therefore, a comparison
with our patient was not possible.
Conclusions
In summary, the clinical findings in our propositus com-
pared to those in patients with similar deletions show
that deletion of the segment 14q24.3-q31.3 is accompan-
ied by a pattern of developmental delay, muscular hypo-
tonia and a relatively non-specific pattern of dysmorphic
findings. Thus, it would be difficult or even impossible
to recognize similar cases on the basis of clinical find-
ings alone.
Methods
Standard GTG banding was performed at a resolution of
400-550 bands on metaphase chromosomes from per-
ipheral blood lymphocytes of the patient and his parents.
Molecular karyotyping was performed on the proband
using through whole-genome array-CGH using a 60-
mer oligonucleotide-based microarray with a theoretical
resolution of 40 kb (8x60K, Agilent Technologies Inc.,
Santa Clara, CA) (Figure 2A,B). Labeling and hybridiza-
tion were performed following the protocols provided by
the manufacturers. Images of the arrays were taken
using a microarray scanner (G2600D) and processed
using Feature Extraction software (v9.5.1), both from
Agilent. The raw data were analyzed by Agilent Cytoge-
nomics v2.7.8.0 software with the statistical algorithm
ADM-2, using a threshold of 6.0 and a 4-probe mini-
mum aberration call.
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